Literature DB >> 32596259

Overcoming Workplace Disability in IBD Patients: An Observational Study.

Emma Paulides1,2, Charlotte Daker1, Chris Frampton1, Richard B Gearry1,3, Tim Eglinton3,4, Nanne K H de Boer2, Charles N Bernstein5, Andrew M McCombie4.   

Abstract

BACKGROUND: Inflammatory Bowel Disease (IBD) can have considerable effects on employment outcomes because of its disabling character. GOALS: We aimed to investigate the impact of IBD in the workplace and to better understand the need for accommodations and adaptations. STUDY: Between November 2017 and March 2018, IBD patients were recruited from outpatient clinics in Christchurch Hospital, New Zealand. The survey assessed employment, the need for workplace accommodations and the difficulty arranging it, insurance, and disability using the item-reduced Inflammatory Bowel Disease Disability Index for self-report (IBD-DI-SR). Data were analyzed using descriptive statistics and multivariate logistic regression modeling.
RESULTS: One hundred twenty-three patients were included (response rate 64%), 112 of whom reported that they experienced symptoms while working (60% female, 71% Crohn's disease, mean age 41.9 years). Ninety-one percent needed at least 1 workplace accommodation when symptoms were most severe. Almost half of the patients who needed an accommodation had difficulty arranging it. The most needed accommodations were time to go to medical appointments (71%) and easy access to a suitable toilet (71%). Being female, having less effective medication, and being distressed were associated with the need for 2 or more accommodations, difficulty in arranging accommodations, and not asking for needed accommodation.
CONCLUSIONS: Many IBD patients need accommodations at work while symptomatic in order to overcome workplace disability, which can be difficult to arrange. Improved resources are needed to inform employees and employers about the disease, the possibilities for workplace accommodations, and practical strategies to request them.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Crohn's disease; Employment; Inflammatory bowel disease; Ulcerative colitis; Workplace disability

Year:  2020        PMID: 32596259      PMCID: PMC7315202          DOI: 10.1159/000506702

Source DB:  PubMed          Journal:  Inflamm Intest Dis        ISSN: 2296-9365


  14 in total

1.  Screening for serious mental illness in the general population.

Authors:  Ronald C Kessler; Peggy R Barker; Lisa J Colpe; Joan F Epstein; Joseph C Gfroerer; Eva Hiripi; Mary J Howes; Sharon-Lise T Normand; Ronald W Manderscheid; Ellen E Walters; Alan M Zaslavsky
Journal:  Arch Gen Psychiatry       Date:  2003-02

2.  Rising Incidence of Inflammatory Bowel Disease in Canterbury, New Zealand.

Authors:  Heidi Y Su; Vikesh Gupta; Andrew S Day; Richard B Gearry
Journal:  Inflamm Bowel Dis       Date:  2016-09       Impact factor: 5.325

3.  Effect of adalimumab on work productivity and indirect costs in moderate to severe Crohn's disease: a meta-analysis.

Authors:  David G Binion; Edouard Louis; Bas Oldenburg; Parvez Mulani; Arielle G Bensimon; Mei Yang; Jingdong Chao
Journal:  Can J Gastroenterol       Date:  2011-09       Impact factor: 3.522

4.  Patients with ulcerative colitis miss more days of work than the general population, even following colectomy.

Authors:  Martin Neovius; Elizabeth V Arkema; Paul Blomqvist; Anders Ekbom; Karin E Smedby
Journal:  Gastroenterology       Date:  2012-12-08       Impact factor: 22.682

5.  Presenteeism in Inflammatory Bowel Diseases: A Hidden Problem with Significant Economic Impact.

Authors:  Aria Zand; Welmoed K van Deen; Elizabeth K Inserra; Laurin Hall; Ellen Kane; Adriana Centeno; Jennifer M Choi; Christina Y Ha; Eric Esrailian; Geert R DʼHaens; Daniel W Hommes
Journal:  Inflamm Bowel Dis       Date:  2015-07       Impact factor: 5.325

6.  Workplace Accommodation for Persons With IBD: What Is Needed and What Is Accessed.

Authors:  Tarun Chhibba; John R Walker; Kathryn Sexton; Gayle Restall; Melony Ivekovic; Leigh Ann Shafer; Harminder Singh; Laura E Targownik; Charles N Bernstein
Journal:  Clin Gastroenterol Hepatol       Date:  2017-06-08       Impact factor: 11.382

7.  Validation of the inflammatory bowel disease disability index for self-report and development of an item-reduced version.

Authors:  Emma Paulides; Catherine Kim; Chris Frampton; Richard B Gearry; Tim Eglinton; Rupert W Leong; Nanne K H de Boer; Chris J J Mulder; Andrew M McCombie
Journal:  J Gastroenterol Hepatol       Date:  2018-10-25       Impact factor: 4.029

Review 8.  Sick leave and disability pension in inflammatory bowel disease: a systematic review.

Authors:  Katharina Büsch; Simone A da Silva; Michelle Holton; Fabiana M Rabacow; Hamed Khalili; Jonas F Ludvigsson
Journal:  J Crohns Colitis       Date:  2014-07-04       Impact factor: 9.071

9.  Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort.

Authors:  Corinne Gower-Rousseau; Hélène Sarter; Guillaume Savoye; Noémie Tavernier; Mathurin Fumery; William J Sandborn; Brian G Feagan; Alain Duhamel; Nathalie Guillon-Dellac; Jean-Frédéric Colombel; Laurent Peyrin-Biroulet
Journal:  Gut       Date:  2015-12-08       Impact factor: 23.059

10.  Prospective validation study of the International Classification of Functioning, Disability and Health score in Crohn's disease and ulcerative colitis.

Authors:  Rupert W L Leong; Tony Huang; Yanna Ko; Ari Jeon; Jeff Chang; Friedbert Kohler; Viraj Kariyawasam
Journal:  J Crohns Colitis       Date:  2014-03-21       Impact factor: 9.071

View more
  1 in total

1.  Inflammatory bowel disease negatively impacts household and family life.

Authors:  Emma Paulides; Demi Cornelissen; Annemarie C de Vries; C Janneke van der Woude
Journal:  Frontline Gastroenterol       Date:  2021-11-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.